🔬

Diagnostics

Diagnostic platforms including liquid biopsy, molecular diagnostics, companion diagnostics, and AI-powered screening.

Companies
0
Pipeline Drugs
105
Key People
56

Diagnostics Pipeline (105 drugs)

Commercial: 80Development: 4Approved/Commercial: 4Development/Commercial: 3Research/Development: 3Various: 2Service/Product: 2Product: 2Approved: 2Launch: 1Clinical Development: 1Platform Technology: 1
DrugCompanyIndicationPhase
Alzheimer's Disease ProgramRocheAlzheimer's DiseaseVarious
Neurological Disorders PortfolioRocheMultiple neurological conditionsVarious
Oncology PipelineRocheVarious cancer typesCommercial
Diagnostic SolutionsRocheDisease prevention and detectionCommercial
Infinity II LC SystemsAgilent TechnologiesDrug discovery and developmentCommercial
6500 Series LC-MS/MSAgilent TechnologiesClinical diagnosticsCommercial
SureSelect Target EnrichmentAgilent TechnologiesCancer genomicsCommercial
Bravo NGS WorkstationAgilent TechnologiesNGS sample preparationCommercial
Seahorse XF AnalyzersAgilent TechnologiesCell metabolism analysisCommercial
PARiS PlatformAgilent TechnologiesPathology AI solutionsCommercial
CologuardExact SciencesColorectal Cancer ScreeningCommercial
Cologuard PlusExact SciencesEnhanced Colorectal Cancer ScreeningDevelopment
CancerguardExact SciencesMulti-Cancer Early DetectionCommercial
Oncotype DX BreastExact SciencesBreast Cancer Treatment GuidanceCommercial
Oncotype DX ColonExact SciencesColon Cancer Treatment GuidanceCommercial
Oncotype DX ProstateExact SciencesProstate Cancer Treatment GuidanceCommercial
ctDNA MonitoringExact SciencesCancer Recurrence MonitoringDevelopment
Detection PlatformsRevvityResearch AnalyticsCommercial
Imaging SolutionsRevvityCell AnalysisCommercial
Laboratory AutomationRevvityWorkflow OptimizationCommercial
Diagnostic SystemsRevvityClinical TestingCommercial
QuantiFERON-TB Gold PlusQiagenTuberculosis TestingCommercial
QIAstat-Dx Syndromic TestingQiagenInfectious DiseaseCommercial
therascreen Solid TumorQiagenOncologyCommercial
ipsogen LeukemiaQiagenLeukemiaCommercial
QIAcuityDxQiagenClinical Digital PCRCommercial
QIAsprint ConnectQiagenHigh-throughput Sample PreparationLaunch
QIAsymphony ConnectQiagenAutomated Clinical Sample ExtractionDevelopment
QIAseq xHYB Viral and Bacterial PanelsQiagenViral and Bacterial DetectionCommercial
QIAstat-Dx Viral Vesicular PanelQiagenMpox Virus DetectionCommercial
Evercode Single-cell RNA-seqQiagenSingle-cell AnalysisCommercial
Routine Laboratory TestingSynlabGeneral health screening and disease monitoringCommercial
Chronic Kidney Disease DiagnosticsSynlabEarly detection and monitoring of CKDCommercial
Rare Disease DiagnosticsSynlabGenetic and molecular diagnosis of rare conditionsCommercial
Pre-Implantation Genetic TestingSynlabGenetic screening of embryos before IVFCommercial
Personalized DiagnosticsSynlabTailored testing based on individual patient profilesCommercial
Fluent® Automation WorkstationTecanLife Sciences Research, Drug Discovery, DiagnosticsCommercial
Veya® Multiomics SuitesTecanGenomics, Proteomics, Multiomics ResearchCommercial
Freedom EVO® / Freedom EVOlyzer®TecanLife Sciences, Diagnostics, Applied MarketsCommercial
Spark® / Spark® Cyto Microplate ReadersTecanCell-based assays, Drug discovery, MicrobiologyCommercial
Infinite® 200 PRO / F50 SeriesTecanLife Sciences Research, Assay DevelopmentCommercial
MagicPrep NGSTecanNext-Generation Sequencing Library PreparationCommercial
D300e Digital DispenserTecanHigh-Throughput Screening, Drug DiscoveryCommercial
Duo Digital DispenserTecanHigh-Throughput Screening, Drug DiscoveryCommercial
Resolvex® Positive Pressure WorkstationsTecanClinical Mass Spectrometry, Sample PreparationCommercial
Immunoassay Automation SolutionsTecanAutoimmunity, Endocrinology, Infectious Disease DiagnosticsCommercial
Anti-Vitamin D (25-OH) AntibodyBioventixVitamin D Status TestingCommercial
Anti-Troponin I AntibodyBioventixMyocardial Infarction (Cardiac Testing)Development/Commercial
Anti-PSA AntibodyBioventixProstate Cancer ScreeningDevelopment/Commercial
Anti-SARS-CoV-2 AntibodyBioventixCOVID-19 Antigen DetectionCommercial